In the present study, the two most common promoter polymorphisms of IL-4, −590C/T (rs2243250) and −33C/T (rs2070874), were evaluated in four Chinese patient groups – patients with CHB, LC, and HBV-related HCC, and a healthy control group – to determine whether these IL-4 gene polymorphisms contribute to the susceptibility of HBV-related HCC. The gene discussed is IL4; the disease is hepatocellular carcinoma.